Mark Rothera

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Mark Rothera

Mark Rothera is recorded as CEO at Silence Therapeutics plc (SLN). Mark Rothera has spoken on 2 earnings calls across 1 company, most recently for Silence Therapeutics plc on August 12, 2021.

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Mark Rothera's recent earnings-call comments and cite the source calls.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Silence Therapeutics plc (SLN)
CEO

Source not stated

Current

Company network

Recorded roles and call appearances connecting this person to public companies.

Silence Therapeutics plc

SLN

Current role

CEO

2 appearances Latest appearance 2021-08-12

View calls and events

Leadership on record at Silence Therapeutics plc

Other people whose current roles at this company are on record from its filings.

Craig Tooman CEO
Iain Ross CEO, Chairman
Rhonda Hellums CFO, Board Member
Dave Lemus Board Member
James Ede-Golightly Board Member
Tim McInerney Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Earnings call Silence Therapeutics plc Q2 FY2021 Earnings Call Silence Therapeutics plc (SLN)
2021-08-12
Earnings call Silence Therapeutics plc Q4 FY2020 Earnings Call Silence Therapeutics plc (SLN)
2020-12-31